VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical tr ...

SAN JOSE, Calif., June 23, 2025--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial ...

SAN JOSE, Calif., June 23, 2025--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study ...

$328M Stroke Rehab Market Now in VSee's Sights On June 23, VSee announced it has been selected to power a UCLA-led, NIH-funded Phase 3 clinical trial for stroke recovery telerehabilitation.

NIH Stroke Scale score was 18 at baseline. Time to randomization was 19.5 hours for the control group and 22 hours for the MIS group. Baseline ICH volume was around 40 mL.